Health care financing policy for hospitalized pediatric patients

E Munoz1, D Chalfin, J Goldstein

  • 1Department of Surgery, Long Island Jewish Medical Center, New Hyde Park, NY 11042.

Insights

Diagnosis Related Group (DRG) all-payer systems may under-reimburse pediatric care. Medicaid patients incurred higher costs and severity, indicating financial risk under current payment models for hospitalized children.

Area of Science:

  • Healthcare financing
  • Hospital reimbursement models
  • Pediatric healthcare economics

Background:

  • Prospective hospital payment systems, particularly Diagnosis Related Groups (DRG), are transforming healthcare reimbursement.
  • Many states have implemented "all-payer systems" based on the federal DRG model, ensuring consistent payment across different insurance providers.
  • These systems aim to prevent cost shifting between payers like Medicaid, Blue Cross, and commercial insurers.

Purpose of the Study:

  • To simulate the impact of DRG all-payer reimbursement methods on pediatric patient care.
  • To analyze financial risks and resource utilization for pediatric patients under New York's DRG all-payer system.
  • To evaluate the adequacy of current reimbursement levels for hospitalized pediatric patients.

Main Methods:

  • A simulation of DRG all-payer methods was conducted.
  • The study analyzed a large sample of 16,084 pediatric patients over a three-year period.
  • Data from New York's established DRG all-payer reimbursement system were utilized.

Main Results:

  • Medicaid pediatric patients exhibited longer hospital stays and higher total costs compared to those covered by Blue Cross and other commercial payers, even after adjusting for DRG weight index.
  • A greater severity of illness was observed in Medicaid pediatric patients relative to patients from other insurance groups.
  • All pediatric patient groups generated financial risk under the DRG all-payer system, with Medicaid patients posing the highest risk.

Conclusions:

  • The DRG all-payer scheme may result in under-reimbursement for the care of hospitalized pediatric patients by state and private payers.
  • Current healthcare financing policies for pediatric care under DRG systems could potentially impact access to and quality of care.
  • There is a need to re-evaluate reimbursement rates to ensure adequate funding for pediatric hospital services.

Related Concept Videos

Methods Of Healthcare Delivery System01:26

Methods Of Healthcare Delivery System

At the different levels of the healthcare system, we see varying methods of healthcare used. These methods include managed care systems, case management, and primary healthcare.
Managed Care System:
The managed care system is designed to control the cost while maintaining the quality of care. The patient's care from admission to discharge is planned by the primary care provider or the case manager, also known as the gatekeeper. In a managed care system, the number of care providers is limited...
Hospitals-I01:28

Hospitals-I

Hospitals offer medical and surgical care to the sick and injured, along with accommodation while they recover. At the same time, they also provide outpatient, emergency, psychiatric, and rehabilitation services to meet various community needs. In addition to providing medical care, hospitals also act as hubs for medical research and training. Hospitals use clinical procedures and evidence-based practice standards to deliver patient care. To deliver safe and efficient care, a nurse must stay up...
Standards of Care I01:22

Standards of Care I

Federal statutes profoundly impact nursing practice, providing critical guidelines to ensure patient care is equitable, accessible, and of the highest quality. The following laws address distinct aspects of healthcare provision and patient rights:
Standards of Care II01:19

Standards of Care II

Nurses bear specific legal responsibilities under several federal statutes, including:
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...